LSTA

$0.00

(

+0.00%

)
Quote details

stock

Lisata Therapeutics Inc.

NASDAQ | LSTA

2.79

USD

+$0.00

(

+0.00%

)

At Close (As of Oct 31, 2025)

$24.43M

Market Cap

-

P/E Ratio

-2.23

EPS

$4.20

52 Week High

$1.87

52 Week Low

HEALTHCARE

Sector

LSTA Chart

Recent Chart
Price Action

LSTA Technicals

Tags:

LSTA Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $1M
Total Revenue $1M
Cost Of Revenue $174K
Costof Goods And Services Sold $174K
Operating Income -$22M
Selling General And Administrative $12M
Research And Development $11M
Operating Expenses $23M
Investment Income Net -
Net Interest Income -
Interest Income -
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $174K
Income Before Tax -$21M
Income Tax Expense -$798K
Interest And Debt Expense -
Net Income From Continuing Operations -$20M
Comprehensive Income Net Of Tax -
Ebit -$22M
Ebitda -$22M
Net Income -$20M

Revenue & Profitability

Earnings Performance

LSTA Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $35M
Total Current Assets $35M
Cash And Cash Equivalents At Carrying Value $16M
Cash And Short Term Investments $16M
Inventory -
Current Net Receivables $900K
Total Non Current Assets $424K
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $192K
Intangible Assets Excluding Goodwill $192K
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $15M
Other Current Assets $2.4M
Other Non Current Assets -
Total Liabilities $5.7M
Total Current Liabilities $5.6M
Current Accounts Payable $1.3M
Deferred Revenue -
Current Debt -
Short Term Debt $274K
Total Non Current Liabilities $72K
Capital Lease Obligations $137K
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $137K
Other Current Liabilities $4.1M
Other Non Current Liabilities $72K
Total Shareholder Equity $30M
Treasury Stock -
Retained Earnings -$548M
Common Stock $8K
Common Stock Shares Outstanding $8.3M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$19M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $174K
Capital Expenditures $0
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment $13M
Cashflow From Financing -$206K
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$20M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $1M
Total Revenue $1M
Cost Of Revenue $174K
Costof Goods And Services Sold $174K
Operating Income -$22M
Selling General And Administrative $12M
Research And Development $11M
Operating Expenses $23M
Investment Income Net -
Net Interest Income -
Interest Income -
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $174K
Income Before Tax -$21M
Income Tax Expense -$798K
Interest And Debt Expense -
Net Income From Continuing Operations -$20M
Comprehensive Income Net Of Tax -
Ebit -$22M
Ebitda -$22M
Net Income -$20M

LSTA News

LSTA Profile

Lisata Therapeutics Inc. Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Lisata Therapeutics Inc. is a clinical-stage biopharmaceutical company headquartered in Basking Ridge, New Jersey, that focuses on innovative cellular therapies designed to reverse diseases and promote tissue regeneration. The company's robust pipeline addresses critical unmet medical needs across multiple therapeutic areas, highlighting its dedication to advancing research and development. By concentrating on transformative healthcare solutions, Lisata Therapeutics is positioned to play a significant role in the biopharmaceutical landscape, presenting a compelling investment opportunity for institutional investors interested in breakthroughs in medicine.

EPWK
+29.15%
$0.08
YDKG
+21.59%
$0.05
VHAI
-17.50%
$0.00
WTO
+6.92%
$0.04
HKD
+74.55%
$2.95
MSAI
+18.18%
$1.56
INTS
-44.68%
$0.73
NVDA
-0.19%
$202.49
AMZN
+9.58%
$244.22
BENF
+48.24%
$0.82
PFE
+1.48%
$24.65
GETY
-6.46%
$1.88
ASST
+9.91%
$1.33
DVLT
-19.44%
$2.02
ONDS
+2.38%
$6.44
BYND
+0.30%
$1.65
BURU
+0.26%
$0.33
BTG
-9.85%
$4.38
PLUG
+1.50%
$2.69
NOK
-3.08%
$6.91
MSPR
-30.29%
$0.22
T
+0.28%
$24.75
CTM
+13.59%
$1.17
DNN
-1.55%
$3.17
AAPL
-0.37%
$270.37
QS
+16.78%
$18.44
TSLA
+3.74%
$456.56
INTC
-0.42%
$39.99
BITF
-2.21%
$3.97
ACHR
+2.37%
$11.22
AZI
+3.38%
$0.09
RIG
-1.79%
$3.84
F
+0.53%
$13.13
NWL
-27.96%
$3.40
AXDX
-61.36%
$0.03
RGTI
+4.11%
$44.27
SOFI
+2.23%
$29.68
GPUS
-7.48%
$0.40
ADTX
-12.64%
$0.05
TGE
-53.70%
$0.77
RANI
+51.72%
$2.20
LAZR
-45.02%
$1.15
CJET
-9.39%
$0.04
META
-2.71%
$648.35
PLTR
+3.04%
$200.47
VZ
+2.00%
$39.74
CAN
+15.32%
$1.43
NIO
+3.42%
$7.25
ADAP
-15.14%
$0.05
CMG
-2.58%
$31.69
LUMN
-0.58%
$10.28
WULF
+4.58%
$15.50
MNOV
+39.49%
$1.66
KVUE
+0.91%
$14.37
VALE
+1.68%
$12.09
SNAP
+2.63%
$7.80
QUBT
+11.62%
$16.71
CCL
+1.76%
$28.83
RIVN
+4.46%
$13.57
AAL
+2.73%
$13.13
CIFR
-2.20%
$18.64
WBD
+3.83%
$22.45
JOBY
+4.77%
$17.34
RXRX
-2.30%
$5.52
GRAB
+0.50%
$6.01
CLF
+1.38%
$12.43
TLRY
+3.87%
$1.34
RMBL
+60.50%
$3.21
BAC
+0.79%
$53.45
GOOGL
-0.10%
$281.19
AMCR
+0.63%
$7.90
ADD
-25.47%
$0.05
ABEV
+0.43%
$2.31
QBTS
+2.63%
$37.06
ETHD
-10.66%
$3.77
BBD
-0.29%
$3.38
CABA
+46.15%
$3.61
SRM
+53.27%
$10.30
AMD
+0.50%
$256.12
MSFT
-1.51%
$517.80
LAES
+7.69%
$7.42
HPE
+0.04%
$24.42
MARA
+2.87%
$18.27
RIOT
-6.21%
$19.78
KDLY
+8.92%
$0.92
NAKA
+8.92%
$0.92
BTBT
+3.38%
$3.66
DFSC
+20.68%
$5.25
APLD
+2.09%
$34.65
KHC
+0.61%
$24.73
FI
+2.30%
$66.69
GOOG
-0.02%
$281.82
MRVL
+5.83%
$93.74
WLGS
-5.57%
$0.04
SOUN
+4.44%
$17.62
IXHL
-6.56%
$0.37
FUBO
+3.27%
$3.78
NVTS
+7.16%
$13.46
ETWO
0.00%
$3.30
DXCM
-14.63%
$58.22
EPWK
+29.15%
$0.08
YDKG
+21.59%
$0.05
VHAI
-17.50%
$0.00
WTO
+6.92%
$0.04
HKD
+74.55%
$2.95
MSAI
+18.18%
$1.56
INTS
-44.68%
$0.73
NVDA
-0.19%
$202.49
AMZN
+9.58%
$244.22
BENF
+48.24%
$0.82
PFE
+1.48%
$24.65
GETY
-6.46%
$1.88
ASST
+9.91%
$1.33
DVLT
-19.44%
$2.02
ONDS
+2.38%
$6.44
BYND
+0.30%
$1.65
BURU
+0.26%
$0.33
BTG
-9.85%
$4.38
PLUG
+1.50%
$2.69
NOK
-3.08%
$6.91
MSPR
-30.29%
$0.22
T
+0.28%
$24.75
CTM
+13.59%
$1.17
DNN
-1.55%
$3.17
AAPL
-0.37%
$270.37
QS
+16.78%
$18.44
TSLA
+3.74%
$456.56
INTC
-0.42%
$39.99
BITF
-2.21%
$3.97
ACHR
+2.37%
$11.22
AZI
+3.38%
$0.09
RIG
-1.79%
$3.84
F
+0.53%
$13.13
NWL
-27.96%
$3.40
AXDX
-61.36%
$0.03
RGTI
+4.11%
$44.27
SOFI
+2.23%
$29.68
GPUS
-7.48%
$0.40
ADTX
-12.64%
$0.05
TGE
-53.70%
$0.77
RANI
+51.72%
$2.20
LAZR
-45.02%
$1.15
CJET
-9.39%
$0.04
META
-2.71%
$648.35
PLTR
+3.04%
$200.47
VZ
+2.00%
$39.74
CAN
+15.32%
$1.43
NIO
+3.42%
$7.25
ADAP
-15.14%
$0.05
CMG
-2.58%
$31.69
LUMN
-0.58%
$10.28
WULF
+4.58%
$15.50
MNOV
+39.49%
$1.66
KVUE
+0.91%
$14.37
VALE
+1.68%
$12.09
SNAP
+2.63%
$7.80
QUBT
+11.62%
$16.71
CCL
+1.76%
$28.83
RIVN
+4.46%
$13.57
AAL
+2.73%
$13.13
CIFR
-2.20%
$18.64
WBD
+3.83%
$22.45
JOBY
+4.77%
$17.34
RXRX
-2.30%
$5.52
GRAB
+0.50%
$6.01
CLF
+1.38%
$12.43
TLRY
+3.87%
$1.34
RMBL
+60.50%
$3.21
BAC
+0.79%
$53.45
GOOGL
-0.10%
$281.19
AMCR
+0.63%
$7.90
ADD
-25.47%
$0.05
ABEV
+0.43%
$2.31
QBTS
+2.63%
$37.06
ETHD
-10.66%
$3.77
BBD
-0.29%
$3.38
CABA
+46.15%
$3.61
SRM
+53.27%
$10.30
AMD
+0.50%
$256.12
MSFT
-1.51%
$517.80
LAES
+7.69%
$7.42
HPE
+0.04%
$24.42
MARA
+2.87%
$18.27
RIOT
-6.21%
$19.78
KDLY
+8.92%
$0.92
NAKA
+8.92%
$0.92
BTBT
+3.38%
$3.66
DFSC
+20.68%
$5.25
APLD
+2.09%
$34.65
KHC
+0.61%
$24.73
FI
+2.30%
$66.69
GOOG
-0.02%
$281.82
MRVL
+5.83%
$93.74
WLGS
-5.57%
$0.04
SOUN
+4.44%
$17.62
IXHL
-6.56%
$0.37
FUBO
+3.27%
$3.78
NVTS
+7.16%
$13.46
ETWO
0.00%
$3.30
DXCM
-14.63%
$58.22

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.